AbbVie today announced the final analysis of the confirmatory Phase 3 MIRASOL trial evaluating the efficacy and safety of ELAHERE® (mirvetuximab soravtansine-gynx) in women with folate receptor alpha ...
The Brighterside of News on MSN3h
Major discovery identifies the cause of ovarian cancerOvarian cancer is the deadliest form of gynecologic cancer, taking the lives of more than 13,000 women in the U.S. each year.
A Buckinghamshire teacher has issued a stark warning to women who suffer a common ailment - after the problem turned out to ...
New research reveals a gap in menopause support for breast cancer survivors and a lack of involvement in decision-making ...
Ovarian cancer affects anyone with ovaries, most commonly women who are older than 50, the NHS explains - here are the ...
Researcher suggests compounds secreted by high-risk MSCs that are detectable in the bloodstream could act as biomarkers for ...
There are three main types of ovarian cancer: epithelial, germ cell, and stromal. Learn about each type’s defining ...
More people with ovarian cancer are surviving longer after diagnosis in Somerset then almost anywhere else in the country, a ...
The NHS has teamed up with the Dianne Oxberry Trust and Target Ovarian Cancer to bring the roadshow to Greater Manchester.
An extensive tumor genomic analysis of individuals with ovarian cancer, led by researchers from Huntsman Cancer Institute at ...
Discover how the "Vienna Index" and "Top Vienna Index," introduced at ESGO 2025, are improving ovarian cancer detection by ...
An extensive tumor genomic analysis of individuals with ovarian cancer, led by researchers from Huntsman Cancer Institute at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback